Bionano Genomics Inc. (BNGO)
NASDAQ · Healthcare
Bionano Genomics Inc. Long Term Debt 2017–2025
Bionano Genomics Inc. annual/quarterly long term debt history from 2018 to 2020. Long term debt refers to financial obligations that are due more than one year in the future.
- Bionano Genomics Inc. long term debt for the quarter ending December 31, 2020 were 16.3M, a 18.72% decrease year-over-year.
- Bionano Genomics Inc. long term debt for 2020 were 16.3M, a 18.72% decrease from 2019.
- Bionano Genomics Inc. long term debt for 2019 were 20.1M, a 122.44% increase from 2018.
- Bionano Genomics Inc. long term debt for 2018 were 9.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Bionano Genomics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2020 | $16 |
| 2019 | $20 |
| 2018 | $9 |
| Bionano Genomics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2020-12-31 | $16 |
| 2019-12-31 | $20 |
| 2018-12-31 | $9 |
Bionano Genomics Inc. Long Term Debt — FAQ
Bionano Genomics Inc. (BNGO) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BNGO's long term debt history?
The chart and table above show Bionano Genomics Inc.'s long term debt by year and by quarter, including the growth rate.